European equities traded in the US as American depositary receipts started the week lower late Monday morning, declining 0.30% to 1,845.08 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by Ascendis Pharma (ASND) and biopharmaceutical company Cellectis (CLLS), which rose 2.3% and 2.1% respectively. They were followed by pharmaceutical company Sanofi (SNY) and brewing company Anheuser-Busch InBev (BUD), which advanced 1.6% and 1.4% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and internet advertising firm Criteo (CRTO), which fell 15% and 4.3% respectively. They were followed by 3D printer company Materialise (MTLS) and software firm SAP (SAP), which were down 3.7% and 2.9% respectively.

From the UK and Ireland, the gainers were led by Akari Therapeutics (AKTX) and Bicycle Therapeutics (BCYC), which increased 4.9% and 3.9% respectively. They were followed by Autolus Therapeutics (AUTL) and Silence Therapeutics (SLN), which were up 3.3% and 1% respectively.

The decliners from the UK and Ireland were led by software company Endava (DAVA) and cruise line operator Carnival (CUK), which lost 8.1% 4.5% respectively. They were followed by communications company WPP (WPP) and Trinity Biotech (TRIB), which were down 3.3% and 3.1% respectively.